The researchers found new hope to help cure lung disease patients cystic fibrosis with drug discovery ivacaftor. As quoted by VOA News from the New England Journal of Medicine, the drug is believed to be able to balance between salt and water content in the airways of the sufferer.

In applying for some patients, the drug showed positive results. Lung function they show progress and the salt content in sweat reduced, which is characteristic of cystic fibrosis disease.

Lung disease can be decreased due to genetic factors. Patients usually complain of difficulty breathing due to a lot of phlegm contained in the respiratory tract. There were also cases of infection in that channel. In fact, the pancreas of patients will also get the bad effects of the emergence of thick sputum.

Often, a person with cystic fibrosis was found to have low life expectancy. And, each patient had a gene mutation that may be different. These drugs offer a “new smile” for people with cystic fibrosis, although researchers say, while this drug can only be applied to patients with specific gene mutations. The number that can be handled by this drug only about four percent of all types of existing cystic fibrosis mutation.